Maravai Lifesciences Holdings, Inc. (MRVI)
3.93
+0.08
(+2.08%)
USD |
NASDAQ |
Jan 09, 16:00
3.94
+0.01
(+0.25%)
After-Hours: 20:00
Maravai Lifesciences Holdings EPS Diluted (Quarterly): -0.1766 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rockwell Medical, Inc. | -0.0487 |
| AdaptHealth Corp. | 0.1636 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.06M |
| Revenue (Quarterly) | 41.63M |
| Total Expenses (Quarterly) | 67.19M |
| Enterprise Value | 880.72M |
| Gross Profit Margin (Quarterly) | 12.14% |
| Profit Margin (Quarterly) | -108.2% |
| Earnings Yield | -21.48% |
| Normalized Earnings Yield | -8.959 |